Table 1: Characteristics of the 20 studies included in the systematic review
StudyStudy
locationStudy designNo. of
participantsSex. no. (%)Age, 
mean ± SDReported
ethnic origin, %*Outcomes measured
Anglin
et al., 198724Los Angeles, USACohort546M: 282 (51.6)F: 264 (48.4)M: 33.6
F: 30.4White: 77.7
Hispanic: 22.3Illicit opioid use; treatment retention; polysubstance use; legal involvement; marital status; employment during treatment; long-term prognosis
Brown
et al., 199325Brooklyn,
USACohort468M: 291 (62.2)F: 177 (37.8)M: 37.7F: 35.8Black: 55.6Hispanic: 44.4Illicit opioid use; polysubstance use; health status; psychological status; legal involvement; marital status; employment during treatment
Camacho
et al., 199626Fort Worth,
USACohort326M: 223 (68.4)F: 103 (31.6)M: 38.0F: 34.0Black: 16Hispanic: 45White: 36Other: 4Methadone dosage; high-risk sexual behaviour
Chatham
et al., 199927Fort Worth,
USACohort405M: 279 (68.9)F: 126 (31.1)M: 37.6F: 34.4Hispanic: 43White: 36Black: 16Illicit opioid use; treatment retention; polysubstance use; health status; psychological status; legal involvement; high-risk sexual behaviour; marital status; employment during treatment
Grella
et al., 201228Los Angeles, USACohort343M: 191 (55.7)F: 152 (44.3)M: 58.3 ± 4.9F: 55.0 ± 4.1White: 71.1Hispanic: 26.8Other: 2.0Health status; psychological status; employment during treatment; long-term prognosis
Haug
et al., 200529San Francisco, USASecondary data analysis78M: 42 (53.8)F: 36 (46.2)M: 42.9 ± 7.95F: 45.5 ± 7.62White: 35Black: 32Hispanic: 12Other: 12Illicit opioid use; polysubstance use; health status; psychological status
Hser
et al., 1990-199130Los Angeles, USACohort720M: 392 (54.4)F: 328 (45.6)M: 33.4F: 30.2White: 74.2Hispanic: 25.8Illicit opioid use; treatment retention; polysubstance use; legal involvement; marital status; employment during treatment
Jimenez-Trevino
et al. , 201131Oviedo,
SpainCohort53M: 41 (77.4)F: 12 (22.6)M: 51.2 ± 10.1F: 49.8 ± 3.8NRLong-term prognosis
Jones
et al., 200532Baltimore,
USARCT55M: 36 (65.5)F: 19 (34.5)M: 37.3 ± 1.2F: 35.0 ± 1.5White: 46Nonwhite: 54Illicit opioid use; treatment retention
Marsh
et al., 198633Fort Worth,
 USACohort175M: 91 (52.0)F: 84 (48.0)M: 26.8F: 24.6Black: 52White: 48Long-term prognosis
Mulvaney
et al., 199934Philadelphia, USACohort548M: 343 (62.6)F: 205 (37.4)NRBlack: 58Hispanic: 42Illicit opioid use; polysubstance use; health status; psychological status; legal involvement; marital status; employment during treatment
Peles
et al., 200635Tel-Aviv,
 IsraelCohort470M: 339 (72.1)F: 131 (27.9)M: 37.3 ± 8.3F: 34.5 ± 7.5"Mainly Israeli"Illicit opioid use; treatment retention; polysubstance use; methadone dosage
Rutherford
et al., 199736Philadelphia, USACohort72M: 44 (61.1)F: 28 (38.9)M: 39.7F: 35.2White: 51.4Black: 45.8Employment during treatment
Savage
et al., 198037Forth Worth, USACohort1483M: 1151 (77.6)F: 332 (22.4)M: 27.4F: 25.9Black: 46.2White: 31.6Hispanic:† 22.2Long-term prognosis
Schiff 
et al., 200738Jerusalem, IsraelSecondary data analysis2683M: 2352 (87.7)F: 331 (12.3)NR"Mainly Israeli"Illicit opioid use; treatment retention; polysubstance use
Schilling 
et al., 199139New York
City, USACohort244M: 135 (55.3)F: 109 (44.7)M: 38.9 ± 8.8F: 34.5 ± 5.8White: 22Black: 54Hispanic: 23Other: 1Illicit opioid use; treatment retention; polysubstance use; high-risk sexual behaviour; marital status; employment during treatment
Schottenfeld 
et al., 199840West Haven, USARCT58M: 39 (67.2)F: 19 (32.8)M: 33.0F: 33.4White: 75.9Not specified: 24.1Illicit opioid use; treatment retention; polysubstance use
Steer 
et al., 198041Philadelphia, USACohort150M: 107 (71.3)F: 43 (28.7)NRBlack: 70White: 30Psychological status
Stenbacka 
et al., 200342Stockholm, SwedenCohort331M: 233 (70.4)F: 98 (29.6)NR"Swedish"Legal involvement
Webber et al., 199943Bronx, USACohort524M: 302 (57.6)F: 222 (42.4)Median age (min-max)M: 37.1 (21.6 to 66.0)F: 34.7 (19.9 to 66.1)Hispanic: 63Black: 23White: 14Illicit opioid use
Note: F = female, GRADE = Grading of Recommendations Assessment, Development and Evaluation,23 M = male, NR = not reported, RCT = randomized controlled trial,
SD = standard deviation.*Some values do not add up to 100 owing to rounding.
†Puerto Rican 9.8%, Mexican American 12.4%.